Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Multi-Arm Study of Magrolimab Combinations in Patients With Myeloid Malignancies

NCT04778410 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT04778410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04778410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Multi-Arm Study of Magrolimab Combinations in Patients With Myeloid Malignancies
Lead sponsor
Gilead Sciences
Phase
Phase 2
Overall status
Terminated
Start date
June 28, 2021
Completion date
March 4, 2024
Enrollment
54 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

myeloid malignancies